|
Hair Loss InformationIs Aldactone The Only Option For Women Over 35 With Acne?
by:
Naweko San-Joyz
Aldactone is generally prescribed as an “off label” skin disease treatment for women. This drug, although intended to help folk with heart problems not zit problems, reduces the creation of the endocrine androgen. Androgenic endocrine promotes excess facial oil secretion.
Less oil secretion limits the possibility of having clogged pores and skin disease flare-ups.
Spironolactone works as an androgenic endocrine receptor blocker. This drug decreases androgenic endocrine creation in the ovaries and adrenal glands.
Side effects from aldactone can include breast tenderness and catamenial irregularity.
For this reason, doctors normally add oral contraceptives like Ortho Tri-Cyclen and Estrostephave to compliment skin disease treatments and ease potential aldactone side effects. Ironically though, aldactone is suggested for women who are not candidates for oral contraceptives.
So should a woman over 35 with skin disease go with spironolactone? According to the American College of Physicians, the answer is “No”.
In the 2004 May/June edition of the American College of Physicians (ACP) promulgated a medical review of studies that tested the effectiveness of aldactone for dominant
hirsutism, acne, or some
in fertile or biological time
women. The ACP review found deficient evidence to recommend aldactone as an skin disease treatment.
Nevertheless, Dr. Diane Thiboutot of Pennsylvania State University, Hershey uses aldactone for female patients with skin disease attended
by a suspected endocrine disorder.
For example, once
a woman experiences a abrupt onset of severe skin disease or skin disease that is coupled with excessive facial hair growth, irregular catamenial periods, accrued libido, dark patches of skin, deepening of the voice, hormone resistance and hair loss, aldactone may be helpful.
Dr. Thiboutot noted that aldactone “seems to control quite well those cystic-type nodules that they [women] get on their lower face and chin.”
Yet Dr. Julie C Harpist Dr. Harpist of the department of medicine at the University of Alabama, Birmingham doesn’t recommend aldactone so easily. Only if neither topical retinoids nor antibiotics have not worked for a woman’s case of skin disease would-be Dr. Harpist then suggest exploitation aldactone for women over 35.
Author of “Acne Messages”, Naweko San-Joyz, says “A woman’s response to androgens is so varied that limiting herself to an androgenic endocrine blockers like aldactone surely makes not guarantee a cure, or even as a quick treatment.”
San-Joyz adds that overrun of androgens is simply one step in a series of potential events that could lead to acne.
Instead of secretion
manipulation with drugs, San-Joyz suggests women with skin disease regulate this conditional exploitation food, stress control and greater awareness of potential skin disease triggers like environmental estrogens.
Women with skin disease have many
treatments options. If a woman makes decide to go with spironolactone, it’s better to get her prescription filled with her gynaecologist rather that her general practitioner.
It’s most likely that the gynaecologist wish be much aware of how a patient may respond to secretion
treatments like aldactone and oral contraceptives, thus devising recovery faster.
Just about the author:
Naweko San-Joyz created the Skin disease Messages program, the only skin disease program to combine the latest scientific research and ancient wisdom to deliver an skin disease cure as unique as the skin disease sufferer. Millions of skin disease problems, billions of skin disease cures. Find your unique skin disease cure with Skin disease Messages. ISBN: 0974912204 accessible at http://www.Noixia.com
Circulated by Article Emporium
| |
